{"id":"https://openalex.org/W7148907929","doi":"https://doi.org/10.1158/1538-7445.am2026-5653","title":"Abstract 5653: Preclinical characterization of LUA004, a novel 5T4-targeting ADC with improved therapeutic window.","display_name":"Abstract 5653: Preclinical characterization of LUA004, a novel 5T4-targeting ADC with improved therapeutic window.","publication_year":2026,"publication_date":"2026-04-03","ids":{"openalex":"https://openalex.org/W7148907929","doi":"https://doi.org/10.1158/1538-7445.am2026-5653"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2026-5653","doi":"https://doi.org/10.1158/1538-7445.am2026-5653","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-5653","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088459093","display_name":"Jinpeng Pei","orcid":"https://orcid.org/0000-0002-3467-5458","observed_orcids":["https://orcid.org/0000-0002-3467-5458"]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jinpeng Pei","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132846011","display_name":"Shaojuan Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shaojuan Zhao","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","2Qilu Pharmaceutical Co., Ltd., Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]},{"raw_affiliation_string":"2Qilu Pharmaceutical Co., Ltd., Jinan, China","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132887657","display_name":"Ying Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ying Huang","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132887508","display_name":"Junfei Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Junfei Wang","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101597144","display_name":"Wei Zheng","orcid":"https://orcid.org/0000-0001-7731-8971","observed_orcids":["https://orcid.org/0000-0001-7731-8971"]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Zheng","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132871566","display_name":"Hai Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hai Wu","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100332891","display_name":"Jie Chen","orcid":"https://orcid.org/0000-0002-1568-8974","observed_orcids":["https://orcid.org/0000-0002-1568-8974"]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jie Chen","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ke Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ke Li","raw_affiliation_strings":["2Qilu Pharmaceutical Co., Ltd., Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Qilu Pharmaceutical Co., Ltd., Jinan, China","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101616350","display_name":"Xinmei Wang","orcid":"https://orcid.org/0009-0002-2131-5741","observed_orcids":["https://orcid.org/0009-0002-2131-5741"]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xinmei Wang","raw_affiliation_strings":["2Qilu Pharmaceutical Co., Ltd., Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Qilu Pharmaceutical Co., Ltd., Jinan, China","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043528707","display_name":"Shuyong Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuyong Zhao","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","2Qilu Pharmaceutical Co., Ltd., Jinan, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]},{"raw_affiliation_string":"2Qilu Pharmaceutical Co., Ltd., Jinan, China","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132917555","display_name":"Ling Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ling Zhang","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100397738","display_name":"Yang\ufffd Yang","orcid":"https://orcid.org/0000-0003-1222-1209","observed_orcids":["https://orcid.org/0000-0003-1222-1209","https://orcid.org/0009-0008-3480-189X"]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Yang","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089827563","display_name":"Daqing Sun","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Daqing Sun","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5132899456","display_name":"Hua Ying","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Hua Ying","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110919239","display_name":"Weikang Tao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267085","display_name":"Qilu Pharmaceutical Co., Ltd. (China)","ror":"https://ror.org/0155cg005","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405267085"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Weikang Tao","raw_affiliation_strings":["1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Shanghai Qilu Pharmaceutical Research and Development Center LTD, Shanghai, China;","institution_ids":["https://openalex.org/I4405267085"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405267085"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"7_Supplement","first_page":"5653","last_page":"5653"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8003000020980835,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8003000020980835,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.025499999523162842,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.0203000009059906,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5t4","display_name":"5T4","score":0.8669999837875366},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cleavable-linkers","display_name":"cleavable linkers","score":0.7720000147819519},{"id":"https://openalex.org/keywords/therapeutic-window","display_name":"therapeutic window","score":0.6100000143051147},{"id":"https://openalex.org/keywords/oncofetal-protein","display_name":"oncofetal protein","score":0.656000018119812},{"id":"https://openalex.org/keywords/lung-squamous-cell-carcinoma","display_name":"lung squamous cell carcinoma","score":0.7089999914169312},{"id":"https://openalex.org/keywords/esophageal-cancer","display_name":"esophageal cancer","score":0.7490000128746033},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.9089999794960022},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6534000039100647},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5054000020027161},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.4634000062942505},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4253000020980835},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.4075999855995178},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.39430001378059387},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3901999890804291},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.3874000012874603},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.36399999260902405},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.34709998965263367},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.3447999954223633},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3409999907016754},{"id":"https://openalex.org/C2776869981","wikidata":"https://www.wikidata.org/wiki/Q3818464","display_name":"Oncofetal antigen","level":5,"score":0.33899998664855957},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.33379998803138733},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.33149999380111694},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.3287000060081482},{"id":"https://openalex.org/C134066672","wikidata":"https://www.wikidata.org/wiki/Q1424639","display_name":"Payload (computing)","level":3,"score":0.31839999556541443},{"id":"https://openalex.org/C20418707","wikidata":"https://www.wikidata.org/wiki/Q189933","display_name":"Microtubule","level":2,"score":0.30410000681877136},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.28999999165534973},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.28380000591278076},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.275299996137619},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.2648000121116638},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.257999986410141},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.2574000060558319}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2026-5653","doi":"https://doi.org/10.1158/1538-7445.am2026-5653","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2026-5653","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.979200005531311}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409626080","https://openalex.org/W2886298782","https://openalex.org/W2741909400","https://openalex.org/W2016453663","https://openalex.org/W2321809039","https://openalex.org/W7148789390","https://openalex.org/W4399345852","https://openalex.org/W7210178173","https://openalex.org/W2616027921","https://openalex.org/W4409624699"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Trophoblast":[2],"glycoprotein":[3],"(5T4),":[4],"an":[5,81],"oncofetal":[6],"protein,":[7],"is":[8,19,39],"a":[9,112,138,145,151,155,171,235,308,321,397],"member":[10],"of":[11,16,66,88,111,159,174,237,346,352,395,408],"the":[12,51,109,312,335,409],"leucine-rich":[13],"repeat":[14],"family":[15],"proteins":[17],"that":[18],"associated":[20],"with":[21,54,71,99,116,144,154,216,262,266,294,325,341,401],"intercellular":[22],"connectivity,":[23],"cell":[24,30,36,176,214,240],"morphology":[25],"and":[26,28,35,47,128,180,208,227,246,284,329],"movement,":[27],"altering":[29],"adhesion":[31],"in":[32,41,59,74,178,184,211,229,250,291,303,311,339],"embryonic":[33],"development":[34,110,357],"differentiation.":[37],"5T4":[38,67,89,218,264],"upregulated":[40],"several":[42,97],"cancers,":[43,49],"including":[44],"esophageal,":[45],"head-and-neck,":[46],"lung":[48],"especially":[50],"squamous":[52],"subtype,":[53],"low":[55],"or":[56],"absent":[57],"expression":[58,65,219],"adult":[60],"normal":[61],"tissues.":[62],"The":[63,85,164,348],"high":[64,336],"was":[68,93,288],"notably":[69],"correlated":[70],"poor":[72],"survival":[73],"different":[75,217,251],"cancer":[76,175,239],"types,":[77],"which":[78,124,332],"makes":[79],"it":[80],"attractive":[82],"ADC":[83,91,115,324,400],"target.":[84],"therapeutic":[86,130,197,313,403],"potential":[87],"as":[90,121,255,257,270],"modality":[92],"recently":[94],"unraveled":[95],"by":[96],"ADCs":[98],"preliminary":[100],"clinical":[101,359],"efficacy":[102,127],"reported.":[103],"In":[104],"this":[105],"study,":[106,306],"we":[107],"present":[108],"novel":[113,139,322,398],"5T4-targeting":[114,323,399],"Qilu\u2019s":[117],"proprietary":[118,146],"microtubule":[119,140,190],"inhibitor":[120,141,191],"payload,":[122],"LUA004,":[123,396],"exhibited":[125],"excellent":[126],"expanded":[129],"window":[131,198,404],"than":[132,199],"vedotin":[133,200],"ADC.":[134],"Method:":[135],"LUA004":[136,203,221,243,276,287,319,353],"utilizes":[137],"payload":[142,165],"QLS8152":[143,166],"cleavable":[147],"linker":[148],"to":[149,232,274,297,316],"achieve":[150],"homogeneous":[152],"product":[153],"drug-to-antibody":[156],"ratio":[157],"(DAR)":[158],"8":[160],"through":[161],"site-specific":[162],"conjugation.":[163],"showed":[167,204,222,244],"sub-nanomolar":[168,205],"activity":[169,328],"across":[170],"wide":[172],"range":[173,225],"lines":[177,215],"vitro":[179,230],"rapid":[181],"systematic":[182],"clearance":[183],"rodent":[185],"models.":[186],"Our":[187],"next":[188],"generation":[189],"platform":[192],"QLS8153":[193],"demonstrated":[194],"significantly":[195],"improved":[196,402],"technology.":[201],"Result:":[202],"binding":[206],"affinity":[207],"dose-dependent":[209,247],"internalization":[210],"multiple":[212],"tumor":[213,248,268],"levels.":[220],"strong":[223],"(nM":[224],"IC50)":[226],"comparable":[228,267],"cytotoxicity":[231],"vedotin-ADC":[233],"against":[234],"variety":[236],"5T4-positive":[238],"lines.":[241],"Meanwhile,":[242],"robust":[245],"inhibition":[249,269],"cell-derived":[252],"xenograft":[253,259],"(CDX)":[254],"well":[256,289],"patient-derived":[258],"(PDX)":[260],"models":[261],"various":[263],"expression,":[265],"vedotin-ADC.":[271,317],"Moreover,":[272],"compared":[273,315],"vedotin-ADC,":[275],"exhibits":[277],"more":[278],"favorable":[279,326],"plasma":[280],"stability,":[281],"preclinical":[282,350],"pharmacokinetic,":[283],"toxicity":[285,305],"profiles.":[286],"tolerated":[290],"cyno":[292],"monkeys,":[293],"HNSTD":[295],"up":[296],"20":[298],"mpk":[299],"Q3W":[300],"x":[301],"4":[302],"non-GLP":[304],"indicating":[307],"tremendous":[309],"increase":[310],"index":[314],"Conclusion:":[318],"represents":[320],"anti-tumor":[327],"superior":[330],"tolerability,":[331],"can":[333],"address":[334],"unmet":[337],"needs":[338],"patients":[340],"cancers":[342],"expressing":[343],"variable":[344],"levels":[345],"5T4.":[347],"promising":[349],"profiles":[351],"warrant":[354],"its":[355],"further":[356],"into":[358],"trials.":[360],"Citation":[361],"Format:":[362],"Jinpeng":[363],"Pei,":[364],"Shaojuan":[365],"Zhao,":[366,382],"Ying":[367],"Huang,":[368],"Junfei":[369],"Wang,":[370,380],"Wei":[371],"Zheng,":[372],"Hai":[373],"Wu,":[374],"Jie":[375],"Chen,":[376],"Ke":[377],"Li,":[378],"Xinmei":[379],"Shuyong":[381],"Ling":[383],"Zhang,":[384],"Yang":[385],"Yang,":[386],"Daqing":[387],"Sun,":[388],"Hua":[389],"Ying,":[390],"Weikang":[391],"Tao.":[392],"Preclinical":[393],"characterization":[394],"[abstract].":[405],"In:":[406],"Proceedings":[407],"American":[410],"Association":[411],"for":[412],"Cancer":[413,431],"Research":[414],"Annual":[415],"Meeting":[416],"2026;":[417],"Part":[418],"1":[419],"(Regular":[420],"Abstracts);":[421],"2026":[422],"Apr":[423],"17-22;":[424],"San":[425],"Diego,":[426],"CA.":[427],"Philadelphia":[428],"(PA):":[429],"AACR;":[430],"Res":[432],"2026;86(7":[433],"Suppl):Abstract":[434],"nr":[435],"5653.":[436]},"counts_by_year":[],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2026-04-04T00:00:00"}